AIM
URGN icon

Assured Investment Management’s UroGen Pharma URGN Stock Holding History

Assured Investment Management’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,990
Closed -$74K – 812
2019
Q1 		$74K Sell
1,990
-7,018
-78% -$294K ﹤0.01% 926
2018
Q4 		$388K Sell
9,008
-4,549
-34% -$205K 0.01% 738
2018
Q3 		$640K Buy
13,557
+5,979
+79% +$278K 0.01% 687
2018
Q2 		$377K Buy
+7,578
New +$441K 0.01% 890

Other funds holding URGN

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Assured Investment Management's URGN Position: Q2 2019 in Review

Assured Investment Management sold out of UroGen Pharma (URGN) in Q2 2019, closing a stake of 1,990 shares — an estimated $74K sold.

Assured Investment Management first reported a position in URGN in Q2 2018 and held it in 4 quarters. The position peaked at $640K in Q3 2018. 84 funds tracked by Wall St. Rank hold URGN as of Q2 2019.

  • Assured Investment Management reported no remaining UroGen Pharma position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 1,990 UroGen Pharma shares in Q2 2019, an estimated $74K.
  • Assured Investment Management first reported a position in UroGen Pharma in Q2 2018 and held it in 4 quarters.
  • Assured Investment Management's UroGen Pharma position peaked at $640K in Q3 2018.
  • 84 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.